Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome

• Fan Xiao,
• Ke Rui,
• Man Han,
• Liyun Zou,
• Enyu Huang,
• Jie Tian,
• Lijun Zhang,
• Quan Jiang,
• Yuzhang Wu,
• Liwei Lu

Affiliations

Fan Xiao

Department of Pathology and Shenzhen Institute of Research and Innovation, Shenzhen Hospital, The University of Hong Kong; Chongqing International Institute for Immunology

Ke Rui

Department of Laboratory Medicine, Affiliated Hospital and Institute of Medical Immunology, Jiangsu University

Man Han

Division of Rheumatology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences

Liyun Zou

Institute of Immunology, Army Medical University

Enyu Huang

Department of Pathology and Shenzhen Institute of Research and Innovation, Shenzhen Hospital, The University of Hong Kong; Chongqing International Institute for Immunology

Jie Tian

Department of Laboratory Medicine, Affiliated Hospital and Institute of Medical Immunology, Jiangsu University

Lijun Zhang

Department of Pathology and Shenzhen Institute of Research and Innovation, Shenzhen Hospital, The University of Hong Kong; Chongqing International Institute for Immunology

Quan Jiang

Division of Rheumatology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences

Yuzhang Wu

Institute of Immunology, Army Medical University

Liwei Lu

Department of Pathology and Shenzhen Institute of Research and Innovation, Shenzhen Hospital, The University of Hong Kong; Chongqing International Institute for Immunology